Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $147,175 | 58 | 88.2% |
| Travel and Lodging | $9,726 | 47 | 5.8% |
| Consulting Fee | $5,024 | 3 | 3.0% |
| Food and Beverage | $4,944 | 123 | 3.0% |
| Education | $37.65 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $143,871 | 149 | $0 (2024) |
| Amgen Inc. | $21,160 | 21 | $0 (2023) |
| Jubilant HollisterStier LLC | $1,000 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $143.35 | 15 | $0 (2018) |
| Shire North American Group Inc | $121.08 | 7 | $0 (2019) |
| Genentech USA, Inc. | $95.36 | 6 | $0 (2024) |
| ALK-Abello, Inc | $77.13 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.46 | 4 | $0 (2019) |
| Grifols USA, LLC | $52.14 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $45.54 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,294 | 52 | AstraZeneca Pharmaceuticals LP ($51,207) |
| 2023 | $52,234 | 50 | AstraZeneca Pharmaceuticals LP ($33,968) |
| 2022 | $50,037 | 46 | AstraZeneca Pharmaceuticals LP ($46,088) |
| 2021 | $6,257 | 9 | AstraZeneca Pharmaceuticals LP ($6,244) |
| 2020 | $773.75 | 3 | AstraZeneca Pharmaceuticals LP ($773.75) |
| 2019 | $5,521 | 20 | AstraZeneca Pharmaceuticals LP ($5,427) |
| 2018 | $382.13 | 27 | Shire North American Group Inc ($44.73) |
| 2017 | $408.69 | 25 | AstraZeneca Pharmaceuticals LP ($141.05) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $134.00 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $70.69 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $363.14 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $138.02 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $107.91 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Travel and Lodging | In-kind items and services | $191.62 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Respiratory | ||||||
| 10/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $53.60 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | AERIN MEDICAL INC. | VIVAER STYLUS (Device), RHINAER STYLUS | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: EAR NOSE & THROAT | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $73.01 | General |
| Category: Respiratory | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: Respiratory | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 449 | 3,550 | $169,746 | $34,202 |
| 2022 | 11 | 441 | 3,464 | $164,139 | $35,417 |
| 2021 | 10 | 460 | 4,149 | $183,511 | $41,831 |
| 2020 | 13 | 508 | 4,571 | $206,835 | $41,632 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 86 | 113 | $33,403 | $9,151 | 27.4% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 62 | 2,365 | $49,665 | $6,473 | 13.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 74 | $14,800 | $4,368 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 51 | 51 | $15,147 | $3,800 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $11,778 | $2,936 | 24.9% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 44 | 447 | $12,963 | $2,641 | 20.4% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 13 | 155 | $6,510 | $1,635 | 25.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 27 | 164 | $10,332 | $1,240 | 12.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 100 | $9,100 | $1,013 | 11.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 29 | 29 | $4,176 | $582.61 | 14.0% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 26 | 26 | $1,872 | $363.22 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 125 | $31,375 | $10,020 | 31.9% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 55 | 2,189 | $45,969 | $6,119 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 77 | $13,167 | $4,376 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $16,340 | $4,331 | 26.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 39 | 39 | $9,750 | $2,828 | 29.0% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2022 | 45 | 433 | $12,557 | $2,716 | 21.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 29 | 263 | $16,569 | $2,013 | 12.1% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 14 | 175 | $7,000 | $1,639 | 23.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 86 | $7,740 | $893.23 | 11.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 16 | 17 | $2,448 | $283.57 | 11.6% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2022 | 16 | 17 | $1,224 | $199.29 | 16.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 146 | $36,646 | $12,102 | 33.0% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 68 | 2,666 | $55,986 | $7,660 | 13.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $20,140 | $6,028 | 29.9% |
About Dr. David Edmondson, DO
Dr. David Edmondson, DO is a Allergy healthcare provider based in Wausau, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124079033.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Edmondson, DO has received a total of $166,907 in payments from pharmaceutical and medical device companies, with $51,294 received in 2024. These payments were reported across 232 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($147,175).
As a Medicare-enrolled provider, Edmondson has provided services to 1,858 Medicare beneficiaries, totaling 15,734 services with total Medicare billing of $153,082. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Allergy
- Other Specialties Clinical & Laboratory Immunology
- Location Wausau, WI
- Active Since 05/15/2006
- Last Updated 04/13/2020
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1124079033
Products in Payments
- TEZSPIRE (Biological) $111,361
- FASENRA (Biological) $47,238
- FASENRA (Drug) $6,112
- BEVESPI AEROSPHERE (Drug) $142.01
- Xolair (Biological) $95.36
- SYMBICORT (Drug) $88.11
- NUCALA (Biological) $77.50
- Odactra (Drug) $60.26
- BREO (Drug) $57.52
- CUVITRU (Biological) $54.89
- DUPIXENT (Biological) $45.54
- SPIRIVA RESPIMAT (Drug) $40.47
- Gamunex-C (Biological) $38.01
- CINRYZE (Drug) $37.65
- Hizentra (Biological) $36.17
- TruDi NAV Cable (Device) $33.14
- TAKHZYRO (Biological) $32.38
- DUPIXENT (Drug) $30.44
- SINUVA (Drug) $24.64
- Aimovig (Biological) $20.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.